Companies /Healthcare

IQVIA Holdings Inc

NYSE: IQV Diagnostics & Research
$268.79
▲ $4.95 (+1.87%) today
Markets open · 3:08pm ET
Today · % change

24/7 Wall St. View

Fundamentals

Market Cap
$42.9B
P/E Ratio
32.4
Profit Margin
8.1%
Revenue (TTM)
$17.0B
EPS (TTM)
$8.04
52-Week Range
$155 – $266
Street Target
$275.17

About IQVIA

IQVIA Holdings Inc. is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. With a presence in the Americas, Europe, Africa, and Asia-Pacific, IQVIA operates across three main segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The company offers a wide range of services including cloud-based applications, real-world evidence generation, strategic consulting, clinical trial support, and healthcare provider engagement. Originally known as Quintiles IMS Holdings, IQVIA is dedicated to improving patient outcomes and informing healthcare decisions through its comprehensive services. Headquartered in Durham, North Carolina, IQVIA serves a diverse clientele including pharmaceutical, biotechnology, and consumer health companies.

IQV Coverage